Consolidated Statement Of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Operating activities
Net income	$ 217	$ 222
Depreciation	123	142
Amortization of intangibles	65	66
Amortization of deferred financing charges	4	4
Unremitted earnings of affiliates	(8)	(1)
Stock compensation expense	14	14
Deferred income taxes	5	(9)
Pension contributions, net	(56)	(204)
Interest payment received on payment-in-kind on note receivable	26
Change in working capital	(75)	(116)
Other, net	(22)	3
Net cash provided by operating activities	293	121
Investing activities
Purchases of property, plant and equipment	(123)	(113)
Acquisition of business	(8)	(7)
Principal payment received on payment-in-kind note receivable	33
Purchases of marketable securities	(80)	(13)
Proceeds from sales of marketable securities	28	12
Proceeds from maturities of marketable securities	7	3
Proceeds from sale of businesses	1	7
Other	8	(3)
Net cash used in investing activities	(134)	(114)
Financing activities
Net change in short-term debt	(11)	26
Proceeds from long-term debt	811	40
Repayment of long-term debt	(55)	(14)
Deferred financing payments	(17)
Preferred stock redemption	(474)
Dividends paid to preferred stockholders	(23)	(23)
Dividends paid to common stockholders	(22)	(22)
Distributions to noncontrolling interests	(11)	(9)
Repurchases of common stock	(288)
Payments to acquire noncontrolling interests	(7)
Other	7	(1)
Net cash used in financing activities	(90)	(3)
Net increase in cash and cash equivalents	69	4
Cash and cash equivalents - beginning of period	1,059	931
Effect of exchange rate changes on cash balances	(7)	5
Cash and cash equivalents – end of period	$ 1,121	$ 940